Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide: <i>In Vitro</i> and <i>In Vivo</i> Effects of PEGylation in the Management of Glioblastoma Multiforme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide: In Vitro and In Vivo Effects of PEGylation in the Management of Glioblastoma Multiforme

Published:2023-06-12 Issue:7 Volume:9 Page:4288-4301
ISSN:2373-9878
Container-title:ACS Biomaterials Science & Engineering
language:en
Short-container-title:ACS Biomater. Sci. Eng.

Author:

Sahoo Rakesh Kumar¹,Kumar Hitesh²,Jain Vikas²^ORCID,Sinha Sonal³,Ajazuddin ³,Gupta Umesh¹^ORCID

Affiliation:

1. Nanopolymeric Drug Delivery Lab, Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Ajmer, Rajasthan 305817, India

2. Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, Karnataka 570015, India

3. Rungta College of Pharmaceutical Sciences and Research, Kohka-Kurud Road, Bhilai, Chhattisgarh 490024, India

Funder

Indian Council of Medical Research

Publisher

American Chemical Society (ACS)

Subject

Biomedical Engineering,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.3c00263

Reference32 articles.

1. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma

2. Review Glioblastoma multiforme – an overview

3. Glioblastoma of the cerebellum and brainstem

4. Cancer Today. https://gco.iarc.fr/today/ (accessed Oct 15, 2022).

5. Harnessing nanomedicine for therapeutic intervention in glioblastoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment;Biomedicines;2024-08-11

2. The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy;Chinese Chemical Letters;2024-05

3. Galectin inhibitors and nanoparticles as a novel therapeutic strategy for glioblastoma multiforme;American Journal of Cancer Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3